Safe Fertility Group (SAFE) Fair Value & Analysis
Healthcare · TH · Market cap 1.8B THB
Fair value as of: Jun 25, 2026
From 26 valuation models · updated 4 days ago
Share price −1.7% over the past month.
Price vs Fair Value (12 months)
12‑month range 5.10 THB – 7.12 THB · fair‑value band 8.25 THB – 13.74 THB · the 5.60 THB price screens below the 10.99 THB fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Safe Fertility Group (SAFE) currently trades at 5.60 THB, while our model-based Fair Value estimate is 10.99 THB — implying the stock looks roughly 96.3% undervalued today. We read business quality at 90/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Safe Fertility Group generated revenue of 700M THB at a net margin of 19.0%. Revenue declined 1.0% year over year. It earns a return on equity of 7.3%. The stock trades on a trailing P/E of 13.6. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
Safe Fertility Group Public Company Limited, together with its subsidiaries, provides fertility medical center services in Thailand. It operates through two segments, Obstetrics and Gynecology hospital and medical laboratory, and Cosmetic Dermatology. The company offers in vitro fertilization, intrauterine insemination, egg freezing, and embryo transfer for women; and sperm freezing and analysis, magnetic activated cell sorting, IMSI, THESIS, and PESA services for men. It also provides couple checkup, embryoscope plus, preimplantation genetic testing for aneuploidies, preimplantation genetic testing for monogenic disorders, and acupuncture for inner body balance. In addition, the company engages in medical laboratories and beauty care service. Safe Fertility Group Public Company Limited was founded in 2007 and is headquartered in Bangkok, Thailand
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Safe Fertility Group reported revenue of 830M THB in FY2025 versus 560M THB in FY2022, a compound +14.0%/yr. Reported net income was 167M THB in FY2025, compounding +28.8%/yr from FY2022.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| 5225 5225 | 8.67 MYR | 3.08 MYR | -64% |
| IHHHF IHHHF | $1.71 | $0.7400 | -57% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Safe Fertility Group (SAFE) undervalued?
What is the fair value of SAFE?
What is the quality score of SAFE?
What is the revenue of Safe Fertility Group (SAFE)?
What is the net profit margin of SAFE?
Does Safe Fertility Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.